My early days with Andreas Roland Grüntzig

Felix Mahler¹

¹Wasserwerkgasse 33 3011 Bern, Switzerland.

European Heart Journal

|August 26, 2017

Summary

No abstract available in PubMed .

Related Concept Videos

You might also read

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Professor Alfred Bollinger January 23, 1932-April 3, 2015.

Lymphology·2016

Same author

[Prof. Dr. med. Alfred Bollinger (1932-2015)].

VASA. Zeitschrift fur Gefasskrankheiten·2015

Same author

CardioPulse: Andreas Grüntzig's beginnings started in peripheral arteries.

European heart journal·2015

Same author

[Raynaud's phenomenon and other circulatory disorders of the fingers].

Praxis·2014

Same author

Nailfold capillaries.

VASA. Zeitschrift fur Gefasskrankheiten·2012

Same author

Nitinol stent implantation versus percutaneous transluminal angioplasty in superficial femoral artery lesions up to 10 cm in length: the femoral artery stenting trial (FAST).

Circulation·2007

Same journal

The surgical collateralization theory: has the beautiful hypothesis been killed by the ugly facts?

European heart journal·2026

Same journal

Beyond single measurement: additional considerations for high-sensitivity C-reactive protein in cardiovascular risk prediction.

European heart journal·2026

Same journal

Brain mineralocorticoid receptor activation and antagonism in heart failure with preserved ejection fraction: a hypothesis.

European heart journal·2026

Same journal

Myths and misconceptions about high-sensitivity C-reactive protein as a marker of residual inflammatory risk.

European heart journal·2026

Same journal

Vascular Ehlers-Danlos syndrome: should we treat asymptomatic patients?

European heart journal·2026

Same journal

Impactful trials on dyslipidaemias, fractional flow reserve, beta-blockers, and peripheral artery disease.

European heart journal·2026

See all related articles

Related Experiment Videos

My early days with Andreas Roland Grüntzig

Related Concept Videos

Professor Alfred Bollinger January 23, 1932-April 3, 2015.

[Prof. Dr. med. Alfred Bollinger (1932-2015)].

CardioPulse: Andreas Grüntzig's beginnings started in peripheral arteries.

[Raynaud's phenomenon and other circulatory disorders of the fingers].

Nailfold capillaries.

Nitinol stent implantation versus percutaneous transluminal angioplasty in superficial femoral artery lesions up to 10 cm in length: the femoral artery stenting trial (FAST).

The surgical collateralization theory: has the beautiful hypothesis been killed by the ugly facts?

Beyond single measurement: additional considerations for high-sensitivity C-reactive protein in cardiovascular risk prediction.

Brain mineralocorticoid receptor activation and antagonism in heart failure with preserved ejection fraction: a hypothesis.

Myths and misconceptions about high-sensitivity C-reactive protein as a marker of residual inflammatory risk.

Vascular Ehlers-Danlos syndrome: should we treat asymptomatic patients?

Impactful trials on dyslipidaemias, fractional flow reserve, beta-blockers, and peripheral artery disease.

Related Experiment Videos

My early days with Andreas Roland Grüntzig

Related Concept Videos

Professor Alfred Bollinger January 23, 1932-April 3, 2015.

[Prof. Dr. med. Alfred Bollinger (1932-2015)].

CardioPulse: Andreas Grüntzig's beginnings started in peripheral arteries.

[Raynaud's phenomenon and other circulatory disorders of the fingers].

Nailfold capillaries.

Nitinol stent implantation versus percutaneous transluminal angioplasty in superficial femoral artery lesions up to 10 cm in length: the femoral artery stenting trial (FAST).

The surgical collateralization theory: has the beautiful hypothesis been killed by the ugly facts?

Beyond single measurement: additional considerations for high-sensitivity C-reactive protein in cardiovascular risk prediction.

Brain mineralocorticoid receptor activation and antagonism in heart failure with preserved ejection fraction: a hypothesis.

Myths and misconceptions about high-sensitivity C-reactive protein as a marker of residual inflammatory risk.

Vascular Ehlers-Danlos syndrome: should we treat asymptomatic patients?

Impactful trials on dyslipidaemias, fractional flow reserve, beta-blockers, and peripheral artery disease.

Related Experiment Videos

My early days with Andreas Roland Grüntzig

Related Concept Videos

Related Articles

Professor Alfred Bollinger January 23, 1932-April 3, 2015.

[Prof. Dr. med. Alfred Bollinger (1932-2015)].

CardioPulse: Andreas Grüntzig's beginnings started in peripheral arteries.

[Raynaud's phenomenon and other circulatory disorders of the fingers].

Nailfold capillaries.

Nitinol stent implantation versus percutaneous transluminal angioplasty in superficial femoral artery lesions up to 10 cm in length: the femoral artery stenting trial (FAST).

The surgical collateralization theory: has the beautiful hypothesis been killed by the ugly facts?

Beyond single measurement: additional considerations for high-sensitivity C-reactive protein in cardiovascular risk prediction.

Brain mineralocorticoid receptor activation and antagonism in heart failure with preserved ejection fraction: a hypothesis.

Myths and misconceptions about high-sensitivity C-reactive protein as a marker of residual inflammatory risk.

Vascular Ehlers-Danlos syndrome: should we treat asymptomatic patients?

Impactful trials on dyslipidaemias, fractional flow reserve, beta-blockers, and peripheral artery disease.

Related Experiment Videos

My early days with Andreas Roland Grüntzig

Related Concept Videos

Related Articles

Professor Alfred Bollinger January 23, 1932-April 3, 2015.

[Prof. Dr. med. Alfred Bollinger (1932-2015)].

CardioPulse: Andreas Grüntzig's beginnings started in peripheral arteries.

[Raynaud's phenomenon and other circulatory disorders of the fingers].

Nailfold capillaries.

Nitinol stent implantation versus percutaneous transluminal angioplasty in superficial femoral artery lesions up to 10 cm in length: the femoral artery stenting trial (FAST).

The surgical collateralization theory: has the beautiful hypothesis been killed by the ugly facts?

Beyond single measurement: additional considerations for high-sensitivity C-reactive protein in cardiovascular risk prediction.

Brain mineralocorticoid receptor activation and antagonism in heart failure with preserved ejection fraction: a hypothesis.

Myths and misconceptions about high-sensitivity C-reactive protein as a marker of residual inflammatory risk.

Vascular Ehlers-Danlos syndrome: should we treat asymptomatic patients?

Impactful trials on dyslipidaemias, fractional flow reserve, beta-blockers, and peripheral artery disease.